{"brief_title": "An Investigational Drug Study in the Treatment of Primary Dysmenorrhea (0663-064)", "brief_summary": "The purpose of this study is to evaluate the pain relieving effect and safety of an investigational drug in women with moderate to severe primary dysmenorrhea (painful menstruation).", "condition": "Dysmenorrhea", "intervention_type": "Drug", "intervention_name": "Comparator: naproxen sodium", "description": "Two etoricoxib 60 mg placebo tablets and one naproxen sodium 550 mg tablet, single-dose, following onset of moderate-to-severe pain due to primary dysmenorrhea", "arm_group_label": "3", "other_name": "naproxen sodium", "criteria": "Inclusion Criteria: - Women 18 years of age or older suffering from painful menstruation Exclusion Criteria: - Women taking medications that are not allowed in the study (such as pain medications, antidepressants, tranquilizers, hypnotics, sedatives, or oral contraceptives). - Women who are pregnant, breast-feeding or within 6 weeks of giving birth", "gender": "Female", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00092729.xml"}